Flagship Biosciences was created by industry leading molecular pathologists to fill the growing need for advanced digital technology in drug development and medical devices. Our pathologists deliver quantitative results so our customers can make efficacy and toxicology assessments faster. We help our clients in many ways:
- Develop histology, IHC, and immunofluorescent biomarkers
- Custom molecular profiling assays in FFPE tissues for DNA and RNA analysis
- Quantitate efficacy and toxicity tissue assays
- Increase visibility between study sponsors and their CROs
- Facilitate partnerships in clinical development
Flagship uses two whole slide scanners to increase throughput in scanning and image analysis
